References
- Koch-Weser J. Serum drug concentrations as therapeutic guides. N Engl J Med 1972: 287(5): 227–31
- Brass EP. Rational approach to therapeutic drug monitoring. Hosp Formul 1985: 20(8): 882–95
- Friedman H, Greenblatt DJ. Rational therapeutic drug monitoring. JAMA 1986: 256(16): 2227–33
- Noone P, Parsons TM, Pattison JR, et al. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J 1974: 1(906): 477–81
- Barza M, Lauermann M. Why monitor serum levels of gentamicin? Clin Pharmacokinet 1978: 3(3): 202–15
- Burgess ED. Friel PN, Blair AD Jr. et al. Serum Phenytoin concentrations in uremia. Ann Intern Med 1981: 94(1): 59–60
- Richens A. Clinical pharmacokinetics of Phenytoin. Clin Pharmacokinet 1979: 4(3): 153–69
- Koch-Weser J. Serum procainamide levels as therapeutic guides. Clin Pharmacokinet 1977: 2(6): 389–402
- Atkinson AJ Jr, Lertora JJ, Kushner W, et al. Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias. Clin Pharmacol Ther 1983: 33(5): 565–76
- Hendeles L, Weinberger M, Johnson G. Monitoring serum theophylline levels. Clin Pharmacokinet 1978: 3(4): 294–312
- Bukowskyj M, Nakatsu K, Munt PW. Theophylline reassessed. Ann Intern Med 1984: 101(1): 63–73
- Pollock J, Kiechel F, Cooper D, et al. Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn. Pediatrics 1977: 60(6): 840–4
- Lanrsen LC. Johannesson N. Sundergaard I. et al. Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion. Br J Clin Pharmacol 1984: 18(4): 591–5
- Jacobs MH, Senior RM, Kessler G. Clinical experience with theophylline: relationships between dosage, serum concentration, and toxicity. JAMA 1976: 235(18): 1983–6
- Zwillich CW, Sutton FD, Neff TA, et al. Theoph- ylline-induced seizures in adults: correlations with serum concentrations. Ann Intern Med 1975: 82(6): 784–7
- Powell JR. Vozeh S. Hopewell P. et al. Theophylline disposition in acutely ill hospitalized patients. Annu Rev Respir Dis 1978: 118: 229–38
- Lee TH, Smith TW. Serum digoxin concentration and diagnosis of digitalis toxicity: current concepts. Clin Pharmacokinet 1983: 8(4): 279–85
- Ingelfinger J A, Goldman P. The serum digitalis concentration: does it diagnose digitalis toxicity? N Engl J Med 1976: 294(16): 867–70
- Aronson JK. Indications for the measurement of plasma digoxin concentrations. Drugs 1983: 26(3): 230–42
- Gibb I, Cowan JC. Parnham AJ, et al. Use and misuse of a digoxin assay service. [Published erratum appears in Br Med J (Clin Res) 1986: 293(6551): 876] Br Med J (Clin Res) 1986: 293(6548): 678–80